Company / Assets per Share
Halozyme Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$20.51
FY2025
5-year range
$8.18 / $20.51
FY2021-FY2025
Trend
+26.0%
vs FY2024
Sector context
#60 of 210
Health Care
What the data says
At $20.51, Halozyme's assets per share ranks #60 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $2.04 in FY2016 to $20.51 in FY2025.
Based on SEC 10-K filings.
20.51 in FY2025 with a 5-year CAGR of +37.0%.
Improved from $12.82 to $20.51 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +15.3%
- 5-Year CAGR
- +37.0%
- 10-Year CAGR
- -
Sector benchmark
#60 of 210 in Health CareTop 29% of 210This company $20.51 Sector average $296.79
▼
-93.1% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 26.0% year-over-year.
- Ranks #60 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.51 | +26.0% |
| FY2024 | $16.28 | +26.9% |
| FY2023 | $12.82 | -4.2% |
| FY2022 | $13.39 | +63.7% |
| FY2021 | $8.18 | +92.8% |
| FY2020 | $4.24 | +8.5% |
| FY2019 | $3.91 | +26.8% |
| FY2018 | $3.08 | -23.2% |
| FY2017 | $4.01 | +96.7% |
| FY2016 | $2.04 | +41.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026